Our computational predictions, supported by molecular docking experiments, confirmed Vorinostat’s strong binding affinity and inhibitory activity against TACE, suggesting its potential for repurposing in the treatment of inflammatory diseases like rheumatoid arthritis. The gene discussed is ADAM17; the disease is rheumatoid arthritis.